Specnova Awarded Patent for Liposomal Ashwagandha

Apr 23 2025

The patent covers the ingredient’s composition, preparation process, and health applications.

Specnova, an ingredient supplier specializing in liposomal technology, announced that its liposomal ashwagandha ingredient NooGandha® has been granted a U.S. patent, which covers the novel composition, preparation process, and cognitive support applications of the nutraceutical, highlighting its distinctive bioactive profile and advanced delivery system.

Written by Mike Montemarano, Nutraceuticals World, April 23, 2025
https://www.nutraceuticalsworld.com/breaking-news/specnova-awarded-patent-for-liposomal-ashwagandha-ingredient-for-cognitive-health/

A Vision of Better Health Through Innovation & Differentiation

Founded by a group of innovators, formulators and industry experts driven by passion and purpose, Specnova is recognized globally as a dependable and trailblazing source of branded ingredients that improve and protect human health. By partnering with us, you align your brand with our commitment to nutritional science and traceable plant extracts from around the world to meet consumer trends.

Learn more about us